Kiniksa Announces Rilonacept Analyst Day Now Tuesday, September 29th

NEXT STORY
Radius Health & Menarini Group Provide Elacestrant Update
PREV STORY
Novavax Initiates Phase 3 Efficacy Trial of COVID-19 Vaccine in the United Kingdom
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021

author_avatar
NASDAQ Market News

vTv Therapeutics Announces Publication in Diabetes Care of Results from SimpliciT-1 Study of TTP399 in Patients with Type 1 Diabetes

author_avatar
NASDAQ Market News

Contraceptive Devices Market to Reach US$ 11,166.4 Mn by 2025, Driven by Optimum Assurance Towards Safety Offered By These Devices, States Fortune Business Insights

author_avatar
NASDAQ Market News